A Retrospective, Non-interventional, Multicenter, Observational Chart Review Study to Explore the Clinical Benefits of Retreatment With TKI in the Real World.

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Locally Advanced or Metastatic EGFR Mutated NSCLC.
Trial Locations (6)

Unknown

Chiayi City

Kaohsiung City

Taichung

Research Site, Taipei

Taipei

Taoyuan District

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY